tiprankstipranks
Eli Lilly and Co (NYSE:LLY) Sues Federal Health Agency over Hospital Drug Discounts
PremiumMarket NewsEli Lilly and Co (NYSE:LLY) Sues Federal Health Agency over Hospital Drug Discounts
6d ago
Wolfe starts J&J at Outperform, sees growth drivers as ‘best-in-class’
Premium
The Fly
Wolfe starts J&J at Outperform, sees growth drivers as ‘best-in-class’
6d ago
Johnson & Johnson initiated with an Outperform at Wolfe Research
Premium
The Fly
Johnson & Johnson initiated with an Outperform at Wolfe Research
6d ago
Johnson & Johnson: FDA grants nipocalimab Breakthrough Therapy designation
PremiumThe FlyJohnson & Johnson: FDA grants nipocalimab Breakthrough Therapy designation
9d ago
Johnson & Johnson submits applications for new indications for Darzalex
Premium
The Fly
Johnson & Johnson submits applications for new indications for Darzalex
13d ago
Johnson & Johnson price target raised to $162 from $156 at Guggenheim
Premium
The Fly
Johnson & Johnson price target raised to $162 from $156 at Guggenheim
15d ago
Johnson & Johnson’s Tremfya shows efficacy in Crohn’s disease Phase 3 study
PremiumThe FlyJohnson & Johnson’s Tremfya shows efficacy in Crohn’s disease Phase 3 study
24d ago
Johnson & Johnson reports results from Phase 3b SPECTREM study
Premium
The Fly
Johnson & Johnson reports results from Phase 3b SPECTREM study
27d ago
Halozyme provides update following EPO decision to revoke Darzalex patent
Premium
The Fly
Halozyme provides update following EPO decision to revoke Darzalex patent
28d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100